KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

Is there a bigger health risk behind your erectile dysfunction (ED)? Here is what you need to know to protect yourself.

The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with ...

As global diabetes rates rise, prevalence of the disease in Canada has stabilized in recent years, with women seeing the most ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

Shocking statistics reveal the rapid rise of diabetes worldwide. Uncover the challenges facing millions and the urgent need ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...